ASH ASHLAND INC.
Wholesale-Chemicals & Allied Products · NYSE · SEC CIK 1674862 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.4%
TTM net income YoY106.0%
TTM EPS YoY105.7%
Revenue 3-yr CAGR-7.2%
Net income 3-yr CAGR-39.8%
Margins
Gross margin31.5%
Operating margin7.4%
Net margin2.8%
FCF margin13.6%
EBITDA margin16.1%
Returns
ROE2.8%
ROA1.1%
ROIC (approx.)2.8%
Asset turnover0.40x
Leverage & solvency
Liabilities / assets59.2%
Debt / equity0.73x
Current ratio3.05x
Interest coverage—
Cash quality & payout
Operating cash flow / net income6.44x
Accruals ratio-6.2%
Payout ratio146.2%
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-06-30 | 2026Q2*2026-03-31 | 2026Q1*2025-12-31 | 2025Q4*2025-09-30 | 2025Q3*2025-06-30 | 2025Q2*2025-03-31 | 2025Q1*2024-12-31 | 2024Q4*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $497.00M | $482.00M | $386.00M | $477.00M | $463.00M | $479.00M | $405.00M | $522.00M |
| Cost of revenue | $327.00M | $335.00M | $281.00M | $318.00M | $331.00M | $332.00M | $294.00M | $348.00M |
| Gross profit | $170.00M | $147.00M | $105.00M | $159.00M | $132.00M | $147.00M | $111.00M | $174.00M |
| R&D expense | $15.00M | $14.00M | $13.00M | $13.00M | $13.00M | $14.00M | $13.00M | $13.00M |
| SG&A expense | $99.00M | $79.00M | $86.00M | $76.00M | $106.00M | $85.00M | $78.00M | $101.00M |
| Operating income | $43.00M | $39.00M | -$6.00M | $61.00M | -$708.00M | $51.00M | -$179.00M | $31.00M |
| Pretax income | $56.00M | $20.00M | -$15.00M | $65.00M | -$704.00M | $39.00M | -$209.00M | $25.00M |
| Income tax | $15.00M | $5.00M | -$1.00M | $32.00M | $15.00M | $9.00M | -$43.00M | $6.00M |
| Net income | $16.00M | $16.00M | -$12.00M | $32.00M | -$742.00M | $31.00M | -$165.00M | $16.00M |
| EBITDA | $75.00M | $69.00M | $42.00M | $111.00M | -$647.00M | $96.00M | -$128.00M | $84.00M |
| EPS (basic) | 0.35 | 0.34 | -0.26 | — | -16.21 | 0.65 | -3.50 | — |
| EPS (diluted) | 0.35 | 0.34 | -0.26 | — | -16.21 | 0.65 | -3.50 | — |
| Dividends declared per share | — | 41.50 | 41.50 | 41.50 | 41.50 | 40.50 | 40.50 | 40.50 |
| Weighted avg. shares (diluted) | 46 | 46 | 46 | — | 46 | 47 | 47 | — |
| Banking | ||||||||
| Net interest income | $8.00M | -$18.00M | -$8.00M | $1.00M | $5.00M | -$11.00M | -$28.00M | $10.00M |
| Balance sheet | ||||||||
| Cash & equivalents | $440.00M | $343.00M | $304.00M | $215.00M | $207.00M | $168.00M | $219.00M | $300.00M |
| Receivables | $256.00M | $244.00M | $190.00M | $242.00M | $201.00M | $226.00M | $163.00M | $243.00M |
| Inventory | $490.00M | $506.00M | $565.00M | $568.00M | $567.00M | $542.00M | $528.00M | $545.00M |
| Current assets | $1.29B | $1.21B | $1.15B | $1.21B | $1.12B | $1.07B | $1.07B | $1.20B |
| PP&E, net | $1.15B | $1.16B | $1.18B | $1.20B | $1.20B | $1.22B | $1.23B | $1.30B |
| Goodwill | $700.00M | $700.00M | $707.00M | $705.00M | $705.00M | $1.36B | $1.33B | $1.38B |
| Intangibles | $513.00M | $529.00M | $548.00M | $563.00M | $578.00M | $580.00M | $588.00M | $751.00M |
| Total assets | $4.58B | $4.50B | $4.52B | $4.61B | $4.62B | $5.23B | $5.23B | $5.64B |
| Current liabilities | $424.00M | $395.00M | $366.00M | $423.00M | $420.00M | $463.00M | $425.00M | $490.00M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $50.00M | — | $0 |
| Long-term debt | $1.37B | $1.37B | $1.39B | $1.38B | $1.38B | $1.34B | $1.31B | $1.35B |
| Total debt | $1.37B | $1.37B | $1.39B | $1.38B | $1.38B | $1.39B | $1.31B | $1.35B |
| Total liabilities | $2.71B | $2.63B | $2.64B | $2.71B | $2.73B | $2.67B | $2.64B | $2.78B |
| Shareholders' equity | $1.87B | $1.87B | $1.88B | $1.90B | $1.89B | $2.56B | $2.59B | $2.87B |
| Net debt | $934.00M | $1.03B | $1.08B | $1.17B | $1.18B | $1.22B | $1.09B | $1.05B |
| Cash flow statement | ||||||||
| Operating cash flow | $120.00M | $50.00M | $125.00M | $40.00M | $115.00M | $9.00M | -$30.00M | $80.00M |
| Capital expenditure | $20.00M | $17.00M | $14.00M | $34.00M | $20.00M | $21.00M | $23.00M | $38.00M |
| Free cash flow | $100.00M | $33.00M | $111.00M | $6.00M | $95.00M | -$12.00M | -$53.00M | $42.00M |
| Investing cash flow | $4.00M | $16.00M | $2.00M | -$3.00M | $1.00M | $17.00M | -$18.00M | $3.00M |
| Financing cash flow | -$20.00M | -$19.00M | -$21.00M | -$18.00M | -$70.00M | -$69.00M | -$22.00M | -$169.00M |
| Depreciation & amortization | $32.00M | $30.00M | $48.00M | $50.00M | $61.00M | $45.00M | $51.00M | $53.00M |
| Stock-based compensation | $6.00M | $5.00M | $4.00M | $3.00M | $3.00M | $5.00M | $4.00M | $5.00M |
| Dividends paid | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M |
| Share buybacks | $0 | — | — | $0 | $0 | $100.00M | $0 | $150.00M |
Free plan shows the latest 8 periods; Pro shows all 51 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.